O

Oramed Pharmaceuticals
D

ORMP

2.33000
USD
-0.02
(-0.85%)
Market Closed
Volume
943
EPS
0
Div Yield
-
P/E
21
Market Cap
93,927,121
Related Instruments
    A
    ARDX
    0.25000
    (5.30%)
    4.96500 USD
    D
    DVAX
    -1.180
    (-8.81%)
    12.210 USD
    K
    KALV
    -0.33000
    (-3.36%)
    9.48000 USD
    O
    OGEN
    -0.01520
    (-4.54%)
    0.31990 USD
    V
    VBLT
    -0.01140
    (-6.65%)
    0.16000 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    More
News

Title: Oramed Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.